Cutler Group LP Galera Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$1.24 - $2.39 $23,560 - $45,410	-19,000 Reduced 93.14%	1,400 $0
Q1 2022 Apr 14, 2022	BUY	$2.01 - $4.19 $27,536 - $57,403	13,700 Added 204.48%	20,400 $1,000
Q4 2021 Jan 18, 2022	BUY	$1.27 - $8.28 $8,509 - $55,475	6,700 New	6,700 $5,000

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.07M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.